Explore
Validate
Learn
Western blotAntibody data
- Antibody Data
- Antigen structure
- References [0]
- Comments [0]
- Validations
- Western blot [1]
- Immunocytochemistry [1]
- Immunohistochemistry [3]
Submit
Validation data
Reference
Comment
Report error
- Product number
- PA5-64240 - Provider product page
- Provider
- Invitrogen Antibodies
- Product name
- ANKRD65 Polyclonal Antibody
- Antibody type
- Polyclonal
- Antigen
- Recombinant full-length protein
- Description
- Immunogen sequence: EEEQELRWME LDSEEALGTR TEGPSVVQGW GHLLQAVWRG PAGLVTQLLR QGH
- Concentration
- 0.3 mg/mL
No comments: Submit comment
Supportive validation
- Submitted by
- Invitrogen Antibodies (provider)
- Main image
- Experimental details
- Western blot analysis of ANKRD65 in Lane 1: Marker (kDa) 250, 130, 95, 72, 55, 36, 28, 17, 10; Lane 2: Human cell line RT-4; Lane 3: Human cell line U-251 MG. Samples were probed using an ANKRD65 Polyclonal Antibody (Product # PA5-64240).
Supportive validation
- Submitted by
- Invitrogen Antibodies (provider)
- Main image
- Experimental details
- Immunofluorescent staining of ANKRD65 in human cell line RT4 using an ANKRD65 Polyclonal Antibody (Product # PA5-64240) shows localization to nucleoplasm.
Supportive validation
- Submitted by
- Invitrogen Antibodies (provider)
- Main image
- Experimental details
- Immunohistochemical staining of ANKRD65 in human fallopian tube shows moderate positivity in ciliated cells. Samples were probed using an ANKRD65 Polyclonal Antibody (Product # PA5-64240).
- Submitted by
- Invitrogen Antibodies (provider)
- Main image
- Experimental details
- Immunohistochemical staining of ANKRD65 in human fallopian tube and kidney tissues using ANKRD65 Polyclonal Antibody (Product # PA5-64240). Corresponding ANKRD65 RNA-seq data are presented for the same tissues.
- Submitted by
- Invitrogen Antibodies (provider)
- Main image
- Experimental details
- Immunohistochemical staining of ANKRD65 in human kidney using ANKRD65 Polyclonal Antibody (Product # PA5-64240) shows low expression as expected.
